IN-DATE
0602190-SD: BD Bard Titanium Implantable Low-Profile Port, Pre-Attached Open-Ended Silicone 6.6F Single-Lumen Venous Catheter, Intermediate Kit
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $199.99 $100.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 4 eaches |
| Expiration: | 10-2026 |
Additional Details
BD Bard Titanium Implantable Low-Profile Port
- Designed to satisfy the placement needs of patients with smaller bodies and those who desire a more discreet placement site.
- Provides repeated access to the vascular system through traditional chest placement (for small and/or cachetic patients) or, alternatively, upper arm placement.
- Indicated for delivery of medications, IV fluids, parenteral nutrition solutions and blood products. Also indicated for withdrawal of blood samples.
- Accepts 25G to 19G non-coring needles.
AccessGUDID Info
- FDA Product Code: LJT
- FDA Product Code Name: PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
- GMDN Term Code: 61494
- GMDN Term Name: Vascular port/catheter
- GMDN Term Description: A fully-implantable device assembly intended to provide access to arteries/veins (excludes coronary and intracerebral circulation) for infusion (e.g., chemotherapeutic agents, blood transfusions) and/or drainage (e.g., blood). It consists of: 1) a subcutaneous chamber, with a self-sealing puncturable septum for percutaneous insertion of a hypodermic needle; and 2) an attached catheter which passes into the arteries/veins. It may consist of two chambers attached to a dual-lumen catheter for simultaneous infusion. It is made of metal [e.g., titanium (Ti)] and/or synthetic polymers (e.g., silicone); disposable devices associated with implantation may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
